Linezolid-associated thrombocytopenia in children with renal impairment

Journal of the Pediatric Infectious Diseases Society

Volumn 4, Issue 3, 2015, Pages 272-275

  Jones, Sara J ^a   Nichols, Kristen R ^b,c,d   DeYoung, Heather L ^d   Cox, Elaine G ^d   Knoderer, Chad A ^b  

^a Lutheran Hospital Fort Wayne   (United States)

^b BUTLER UNIVERSITY   (United States)

^c INDIANA UNIVERSITY HEALTH   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Children; Linezolid; Pediatric; Renal impairment; Thrombocytopenia

Indexed keywords

LINEZOLID; ANTIINFECTIVE AGENT; CREATININE;

ADOLESCENT; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; ENZYMATIC ASSAY; FEMALE; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT OUTCOME; BLOOD; CHEMICALLY INDUCED; INFANT; KIDNEY FAILURE; PRESCHOOL CHILD;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CREATININE; FEMALE; HUMANS; INFANT; LINEZOLID; MALE; PLATELET COUNT; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA;

EID: 85006223085     PISSN: 20487193     EISSN: 20487207     Source Type: Journal    
DOI: 10.1093/jpids/piu035     Document Type: Article

References (16)

1. Chiappini E, Conti C, Galli L, de Martino M. Clinical efficacy and tolerability of linezolid in pediatric patients: a systematic review. Clin Ther 2010; 32:66-88.
2. Jantausch BA, Deville J, Adler S, et al. Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens. Pediatr Infect Dis J 2003; 22:S164-71.
3. Yogev R, Patterson LE, Kaplan SL, et al. Linezolid for the treatment of complicated skin and skin structure infections in children. Pediatr Infect Dis J 2003; 22:S172-7.
4. Stalker DJ, Jungbluth GL. Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial. Clin Pharmacokinet 2003; 42:1129-40.
5. Nukui Y, Hatakeyema K, Yamamoto T, et al. High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia. J Antimicrob Chemother 2013; 68:2128-33.
6. Lin Y, Wu V, Tsai I, et al. High frequency of linezolid associated thrombocytopenia among patients with renal insufficiency. Int J Antimicrob Agents 2006; 28:345-51.
7. Wu V, Wang Y, Wang C, et al. High frequency of linezolid-associated thrombocytopenia and anemia among patients with endstage renal disease. Clin Infect Dis 2006; 42:66-72.
8. Matsumoto K, Takeshita A, Ikawa K, et al. Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction. Int J Antimicrob Agents 2010; 26: 179-81.
9. Hiraki Y, Tsuji Y, Matsumoto K, et al. Influence of linezolid clearance on the induction of thrombocytopenia and reduction of hemoglobin. Am J Med Sci 2011; 342:456-60.
10. Hiraki Y, Tsuji Y, Hiraike M, et al. Correlation between serum linezolid concentration and the development of thrombocytopenia. Scand J Infect Dis 2012; 44:60-4.
11. Meissner HC, Townsend T, Wenman W, et al. Hematologic effects of linezolid in young children. Pediatr Infect Dis J 2003; 22(9 Suppl):S186-92.
12. Kaplan SL, Afghani B, Lopez P, et al. Linezolid for the treatment of methicillin-resistant Staphylcoccus aureus infections in children. Pediatr Infect Dis J 2003; 22:S178-85.
13. Matsumoto K, Takeda Y, Takeshita A, et al. Renal function as a predictor of linezolid-induced thrombocytopenia. Int J Antimicrob Agents 2009; 33:97-98.
14. Takahashi Y, Takesue Y, Nakajima K, et al. Risk factors associated with the development of thrombocytopenia in patients who received linezolid therapy. J Infect Chemother 2011; 17:382-287.
15. Hersh AL, Lee BR, Hedican EB, et al. Linezolid use in hospitalized children. Pediatr Infect Dis J 2014; 33:e14-8.
16. Bernstein WB, Trotta RF, Rector JT, et al. Mechanisms for linezolid-induced anemia and thrombocytopenia. Ann Pharmacother 2003; 37:517-20.